Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYNational Lipid Association’s New Position Statement on Use of Icosapent Ethyl in High and Very-High-Risk Patients Recognizes Importance of Addressing Residual Cardiovascular Risk in Patients on StatinsPREV STORYHelsinn and Mundipharma China Pharmaceutical jointly announce NMPA’s approval of the oral formulation of Akynzeo® in China
